| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/17/2009 | US20090312272 Transglutaminase inhibitors and methods of use thereof |
| 12/17/2009 | US20090312271 Method For Elevating Prolactin in Mammals |
| 12/17/2009 | US20090312270 Peptides having an ace inhibiting effect |
| 12/17/2009 | US20090312266 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1 having proangiogenic activity |
| 12/17/2009 | US20090312265 Novel antimicrobial peptides and use thereof |
| 12/17/2009 | US20090312264 Squamous Cell Carcinoma Antigen-Derived Peptide Binding to HLA-A24 Molecule |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312262 Peptide compound with biological activity, its preparation and its applications |
| 12/17/2009 | US20090312260 Drug therapy for celiac sprue |
| 12/17/2009 | US20090312259 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 12/17/2009 | US20090312258 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312257 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312256 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312255 Stimulation of trpv1+ sensory neurons to control beta-cell stress and islet inflammation in diabetes |
| 12/17/2009 | US20090312254 Long-acting polypeptides and methods of producing same |
| 12/17/2009 | US20090312253 Methods of effecting Wnt signaling through Dkk structural analysis |
| 12/17/2009 | US20090312252 Antimicrobial Activity in Variants of Lacritin |
| 12/17/2009 | US20090312251 Methods of regulating differentiation in mammals |
| 12/17/2009 | US20090312250 Epidermal growth factor increasing insulin secretion and lowering blood glucose |
| 12/17/2009 | US20090312249 TLR4 decoy receptor protein |
| 12/17/2009 | US20090312248 Antimicrobial protein |
| 12/17/2009 | US20090312247 Natriuretic peptide related fragment in cardiovascular disease |
| 12/17/2009 | US20090312246 Uses of Glucoregulatory Proteins |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 12/17/2009 | US20090312243 Treatment of inflammatory bowel disease (ibd) with anti-angiogenic compounds |
| 12/17/2009 | US20090312242 Flibanserin for the treatment of urinary incontinence and related diseases |
| 12/17/2009 | US20090312241 Macrocyclic Compounds as Antiviral Agents |
| 12/17/2009 | US20090312240 Synthesis of Sialic Acid in Plants |
| 12/17/2009 | US20090312239 Preparation, for use, in particular, for tissue augmentation and healing |
| 12/17/2009 | US20090312238 Protection Against Oxidative Damage in Cells |
| 12/17/2009 | US20090312237 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling garnitine content in muscle |
| 12/17/2009 | US20090312236 Pegylated insulin lispro compounds |
| 12/17/2009 | US20090312235 Method for producing insulin in the form of an oral preparation |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311718 Degraded agonist antibody |
| 12/17/2009 | US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/17/2009 | US20090311665 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311350 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 12/17/2009 | US20090311344 Dosing Regimen |
| 12/17/2009 | US20090311338 Crosslinking methods and applications thereof |
| 12/17/2009 | US20090311329 Casein micelles for nanoencapsulation of hydrophobic compounds |
| 12/17/2009 | US20090311326 Pulmonary Insulin Crystals |
| 12/17/2009 | US20090311323 Autologous somatic cells from peripheral blood and uses thereof |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311292 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| 12/17/2009 | US20090311283 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 12/17/2009 | US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine |
| 12/17/2009 | US20090311281 Novel method for down-regulation of amyloid |
| 12/17/2009 | US20090311280 Novel tnf receptor regulatory domain |
| 12/17/2009 | US20090311278 Novel teleost derived antimicrobial polypeptides |
| 12/17/2009 | US20090311277 Nucleic acid compositions for stimulating immune responses |
| 12/17/2009 | US20090311276 Nanolipoprotein particles and related compositions, methods and systems |
| 12/17/2009 | US20090311275 Carrier for targeting nerve cells |
| 12/17/2009 | US20090311270 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311269 Methods for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311268 Cd40-binding activating antibodies |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311250 Methods and compositions for the diagnosis and treatment of cancer |
| 12/17/2009 | US20090311247 Molecules and chimeric molecules thereof |
| 12/17/2009 | US20090311246 Method of Enhancing Remyelination in Demyelinating Diseases of the Central Nervous System |
| 12/17/2009 | US20090311242 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 12/17/2009 | US20090311240 VEGF165 Delivered by Fibrin Sealant to Reduce Tissue Necrosis |
| 12/17/2009 | US20090311239 Recombinant or transgenic factor vii composition, each factor vii molecule having two n-glycosylation sites with defined glycan units |
| 12/17/2009 | US20090311238 Topical composition and treatment method for cartilage damage |
| 12/17/2009 | US20090311237 Combination therapy using a soluble hyaluronidase and a bisphosphonate |
| 12/17/2009 | US20090311236 Therapeutic Peptide Compositions And Methods Of Making And Using Same |
| 12/17/2009 | US20090311235 Use of Polymeric Materials with Other Substances for Improved Performance |
| 12/17/2009 | US20090311234 Use of beta-lactamase |
| 12/17/2009 | US20090311233 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 12/17/2009 | US20090311232 Agent for use in the case of fructose intolerance |
| 12/17/2009 | US20090311231 Product and process for liquefaction of mucus or sputum |
| 12/17/2009 | US20090311230 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/17/2009 | US20090311225 Compositions of and Methods of Using Stabilized PSMA Dimers |
| 12/17/2009 | US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2 |
| 12/17/2009 | US20090311223 Treatment of erectile dysfunction by stem cell therapy |
| 12/17/2009 | US20090311217 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/17/2009 | US20090311216 Recombinant interferon-beta with enhanced biological activity |
| 12/17/2009 | US20090311215 Method for treating cervical cancer |
| 12/17/2009 | US20090311214 Compositions and methods for the innate immune response pathway |
| 12/17/2009 | US20090311213 Methods and compositions for treatment of retinoid-responsive conditions |
| 12/17/2009 | US20090311203 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials |
| 12/17/2009 | US20090311197 Method and Compositions for Oral Hygiene |
| 12/17/2009 | US20090311184 High penetration prodrug compositions of peptides and peptide-related compounds |
| 12/17/2009 | US20090311180 Protein Isoforms and Uses Thereof |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | US20090308324 Diabetes tests |
| 12/17/2009 | DE10315030B4 Zyklische Peptide, Verfahren zu deren Herstellung und deren medizinische Verwendung Cyclic peptides, process for their preparation and to their medical use |
| 12/17/2009 | CA2728248A1 Telaprevir dosing regimen |
| 12/17/2009 | CA2727898A1 Novel antiviral peptides against influenza virus |
| 12/17/2009 | CA2727825A1 Pegylated insulin lispro compounds |
| 12/17/2009 | CA2727657A1 Anti-angiogenic compositions and therapeutic applications thereof |
| 12/17/2009 | CA2727633A1 Use of mir-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
| 12/17/2009 | CA2727622A1 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 12/17/2009 | CA2727392A1 Conditioned medium of liver progenitor cells |
| 12/17/2009 | CA2727317A1 Melanocortin receptor-specific peptides for treatment of sexual dysfunction |